These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Diagnosis and therapy of the hyperkinetic heart syndrome]. Lydtin H, Schnelle K, Lohmöller G, Kusus T. Verh Dtsch Ges Inn Med; 1969 Apr 14; 75():402-5. PubMed ID: 4395391 [No Abstract] [Full Text] [Related]
7. [Beta receptor blocking agents in hypercirculatory syndromes and in high performance athletes]. Gattenlöhner W, Schneider KW, Rost R. Med Welt; 1969 Oct 18; 42():2298-306. PubMed ID: 4901510 [No Abstract] [Full Text] [Related]
9. The effects of propranolol in essential circulatory hyperkinesis. Török E, Matos L, Rausch J, Simonyi J. Int Z Klin Pharmakol Ther Toxikol; 1969 Jul 18; 2(3):246-52. PubMed ID: 4902019 [No Abstract] [Full Text] [Related]
10. [Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type]. Orlov LL, Makoeva LD, Glezer MG, Memetov KA, Belinskaia TF, Arzhanenko OM. Kardiologiia; 1991 Feb 18; 31(2):36-9. PubMed ID: 2041288 [No Abstract] [Full Text] [Related]
11. [Efficacy of treating patients with vegetative and vascular crises of a neurotic nature (comparative electrophysiologic study)]. Veĭn AM, Tabeeva GR, Iakhno NN. Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Feb 18; 86(5):684-8. PubMed ID: 2874677 [Abstract] [Full Text] [Related]
12. Effects of beta-receptor blocking agents propranolol and practolol on ST-T changes in neurocirculatory asthenia. Wolf E, Braun K, Stern S. Br Heart J; 1974 Sep 18; 36(9):872-9. PubMed ID: 4425601 [No Abstract] [Full Text] [Related]
16. [Clinical symptoms and the diagnosis of the hyperkinetic cardiac syndrome]. Abbakumov SA, Bazhanov NN, Kapeliovich MR. Kardiologiia; 1980 Nov 18; 20(11):36-9. PubMed ID: 6108381 [Abstract] [Full Text] [Related]
17. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)]. Guardigli R. Minerva Cardioangiol; 1970 Feb 18; 18(2):131-40. PubMed ID: 4393800 [No Abstract] [Full Text] [Related]
18. [Indications for beta-blockers in other cardiac diseases: rhythm disorders, obstructive cardiomyopathy, cardiothyreosis and neurocirculatory asthenia]. Guize L, Le Heuzey JY. Rev Prat; 1984 Apr 01; 34(19):967-72. PubMed ID: 6144163 [No Abstract] [Full Text] [Related]
19. [Length of effect of beta-blockers in hyperkinetic heart syndrome]. Paulsen HF, Felder K. ZFA (Stuttgart); 1983 Jul 20; 59(20):1149-54. PubMed ID: 6137915 [No Abstract] [Full Text] [Related]
20. [Juvenile hypertension and idiopathic hyperkinetic heart syndrome]. Hayashi T, Yagi S. Nihon Rinsho; 1984 Feb 20; 42(2):455-9. PubMed ID: 6716700 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]